Literature DB >> 24735001

Prolonged altered mental status and bradycardia following pediatric donepezil ingestion.

F M Garlich1, K Balakrishnan, S K Shah, M A Howland, J Fong, L S Nelson.   

Abstract

CONTEXT: Donepezil is a centrally-acting, reversible acetylcholinesterase inhibitor that is used in the treatment of Alzheimer disease. Altered mental status, nausea, vomiting, and bradycardia have been reported in therapeutic and supratherapeutic ingestions of donepezil, though pediatric exposures have not been well-described. We report a case of prolonged altered mental status and recurrent bradycardia in a child with a single-pill ingestion of donepezil. CASE DETAILS: A 14-month-old boy was brought to the Emergency Department 3 hours after ingesting one of his grandfather's donepezil tablets (10 mg). Upon arrival, he was somnolent and drooling, with multiple episodes of vomiting and diarrhea. Pupils were normal. Initial vitals: temperature, 36.8°C; blood pressure, 103/56 mmHg; heart rate, 140/min; respiratory rate, 36/min; oxygen saturation, 97%. His drooling, vomiting, and diarrhea resolved, but he remained intermittently agitated. Over the course of the following four days, he had intermittent, episodes of asymptomatic bradycardia to a low of 55/min, primarily when sleeping. A transient episode of junctional rhythm was observed. Serum donepezil level 97 hours post-ingestion was 10 ng/ml. He did not require atropine treatment, and was discharged in stable condition on hospital day 5. DISCUSSION: Donepezil has a prolonged elimination of half-life in adults of approximately 70 hours. Despite its relative specificity for central AChEs, peripheral cholinergic symptoms have been described. We report a case of a symptomatic ingestion of donepezil in a child.
CONCLUSIONS: Even after a single-tablet ingestion, donepezil may cause prolonged altered mental status and bradycardia in young children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24735001     DOI: 10.3109/15563650.2014.900182

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  4 in total

Review 1.  Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols.

Authors:  Arslan Iftikhar; Rimsha Nausheen; Humaira Muzaffar; Muhammad Ahsan Naeem; Muhammad Farooq; Mohsin Khurshid; Ahmad Almatroudi; Faris Alrumaihi; Khaled S Allemailem; Haseeb Anwar
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

2.  Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic System.

Authors:  Qing-Qing Xu; Yi-Jun Xu; Cong Yang; Ying Tang; Lin Li; Hao-Bin Cai; Bo-Nan Hou; Hui-Fang Chen; Qi Wang; Xu-Guang Shi; Shi-Jie Zhang
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

3.  Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion.

Authors:  Mahdieh Sadeghi; Zakaria Zakariaei; Mostafa Soleymani; Abdollah Malakian
Journal:  Clin Case Rep       Date:  2022-02-20

4.  Fabrication and evaluation of novel quercetin-conjugated Fe3O4-β-cyclodextrin nanoparticles for potential use in epilepsy disorder.

Authors:  Mona Hashemian; Maryam Ghasemi-Kasman; Shahram Ghasemi; Atefeh Akbari; Monire Moalem-Banhangi; Leila Zare; Seyed Raheleh Ahmadian
Journal:  Int J Nanomedicine       Date:  2019-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.